anti-ApoE4 antibody (Tel Aviv University/Ramot at Tel Aviv/Neurimmune)

N/A

Report date: 2025/01/26 19:19:29

Base Information

Drug Nameanti-ApoE4 antibody (Tel Aviv University/Ramot at Tel Aviv/Neurimmune)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionApolipoprotein E4 inhibitors
TargetsApolipoprotein E4
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerlandIsrael
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTel Aviv University
China Registration ClassN/A

Develop Information

Active CompaniesRamot At Tel Aviv UniversityTel Aviv UniversityNeurimmune Ag
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A